Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Thereson Jan 19, 2010 4:22pm
648 Views
Post# 16696713

last trade

last trade

Time ET Ex Price Change Volume Buyer Seller Markers
15:59:56 V 0.37 0.035 1,000 7 TD Sec 81 HSBC K
15:59:56 V 0.37 0.035 9,000 79 CIBC 81 HSBC K
15:59:52 V 0.38 0.045 5,000 85 Scotia 1 Anonymous K
15:59:31 V 0.38 0.045 5,000 85 Scotia 1 Anonymous K
15:59:29 V 0.37 0.035 9,000 79 CIBC 9 BMO Nesbitt K
15:59:15 V 0.37 0.035 12,500 7 TD Sec 7 TD Sec K
15:59:14 V 0.37 0.035 500 85 Scotia 85 Scotia K
15:59:14 V 0.37 0.035 22,000 79 CIBC 85 Scotia K
15:58:57 V 0.37 0.035 4,000 85 Scotia 85 Scotia K
15:58:57 V 0.37 0.035 10,000 79 CIBC 19 Desjardins K

?
Bullboard Posts